Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale)

Experimental and Toxicologic Pathology

Volumn 64, Issue 4, 2012, Pages 315-319

  Oboh, Ganiyu ^a   Ademiluyi, Adedayo O ^a   Akinyemi, Ayodele J ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Brain; Quinolinic acid; Rat; Red ginger; Sodium nitroprusside; White ginger

Indexed keywords

ACETYLCHOLINESTERASE; ALKALOID; FLAVONOID; GINGER EXTRACT; MALONALDEHYDE; NITROPRUSSIDE SODIUM; PLANT MEDICINAL PRODUCT; QUINOLINIC ACID; RED GINGER EXTRACT; TANNIN DERIVATIVE; TERPENOID; UNCLASSIFIED DRUG; WHITE GINGER EXTRACT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GINGER; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; RAT; RED GINGER; VARIETAS; WHITE GINGER;

ANIMALS; ANTIOXIDANTS; BRAIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GINGER; LIPID PEROXIDATION; MALE; NITROPRUSSIDE; PLANT EXTRACTS; QUINOLINIC ACID; RATS; RATS, WISTAR; SPECIES SPECIFICITY;

ALPINIA PURPURATA; HEDYCHIUM CORONARIUM; RATTUS; ZINGIBER OFFICINALE;

EID: 84859424318     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.09.004     Document Type: Article

References (45)

1. Ahmad B., Siddig I., Adel S.A., Manal M.E.T., Syam M.M. Zerumbone: a natural compound with anti-cholinesterase activity. Am J Pharmacol Toxicol 2008, 3(3):209-211.
2. Akhondzadeh S., Abbasi S.H. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Dement 2006, 21:113-118.
3. Arnold S.E., Kumar A. Reversible dementias. Med Clin N Am 1993, 77:215-225.
4. Bachman D.L., Wolf P.A., Linn R.T. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992, 42:115-119.
5. Behan W.M., McDonald M., Darlington L.G., Stone T.W. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol 1999, 128:1754-1760.
6. Belle N.A.V., Dalmolin G.D., Fonini G., Rubim M.A., Rocha J.B.T. Polyamines reduces lipid peroxidation induced by different prooxidants agents. Brain Res 2004, 1008:245-251.
7. Bierer L.M., Haroutunian V., Gabriel S. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995, 64:749-760.
8. Bouchet N., Barrier L., Fauconneau B. Radical scavenging activity and antioxidant properties of tannins from Guiera senegalensis (Combretaceae). Phytother Res 1998, 12:159-162.
9. Breitner J.C.S. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 1996, 47:401-411.
10. Cabrera J., Reiter R.J., Tan D., Qi W., Sainz R.M., Mayo J.C., et al. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 2000, 39:507-514.
11. Chevallier A. The encyclopedia of medicinal plants 1996, Dorling Kindersley, London, 336pp. ISBN 9-780751-303148.
12. Conforti F., Statti G.A., Tundis R., Loizzo M.R., Menichini F. In vitro Activities of Citrus medica L. cv. Diamante (Diamante citron) relevant to Treatment of Diabetes and Alzheimer's disease. Phytother Res 2007, 21:427-433.
13. Finkel T., Holbrook N.J. Oxidative stress and biology of ageing. Nature 2008, 408:239-247.
14. Guillemin G.J., Brew B.J. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. J Neuroinflammat 2002, 7:199-206.
15. Guillemin G.J., Kerr S.J., Brew B.J. Involvement of quinolinic acid in AIDS dementia complex. Neurotox Res 2004, 7:103-124.
16. Guillemin G., Meininger V., Brew B. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegenerat Dis 2006, 2:166-176.
17. Howes M.J.R., Perry N.S.L., Houghton P.J. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 2003, 17:1-18.
18. Keith S. Medicinal Seasoning. South Africa: Medspice CC; 2006, 93pp. ISBN 0-620-35984-6.
19. Kim D.S., Kim D.S., Oppel M.N. Shogaols from Zingiber officinale protect IMR32 human neuroblastoma and normal human umbilical vein endothelial cells from beta-amyloid(25-35) insult. Planta Med 2002, 68(4):375-376.
20. Liu G., Zhang T., Wang B., Wang Y. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 1992, 47:549-553.
21. Marksberry W.R., Lovell M.A. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch Neurol 2007, 64:954-956.
22. Maruyama M., Tomita N., Iwasaki K. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial. J Am Geriatr Soc 2006, 54:869-871.
23. Mazza M., Capuano A., Bria P., Mazza S. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur J Neurol 2006, 9:981-985.
24. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
25. 2+ - induced lipid peroxidation in Brain - in vitro. Food Chem 2007, 102(1):178-185.
26. Oboh G., Rocha J.B.T. Distribution and antioxidant activity of polyphenols in ripe and unripe tree pepper (Capsicum pubescens). J Food Biochem 2007, 31:456-473.
27. Oboh G., Rocha J.B.T. Water extractable phytochemicals from Capsicu pubescens (tree pepper) inhibit lipid peroxidation induced by different pro-oxidant agents in brain: in vitro. Eur Food Res Technol 2008, 226:707-713.
28. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
29. Orhan I., Sener B., Choudhary M.I., Khalid A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol 2004, 91:57-60.
30. Parihar M.S., Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004, 11:456-467.
31. Perry N.S., Houghton P.J., Jenner P., Keith A., Perry E.K. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine 2002, 9:48-51.
32. Perry N.S., Houghton P.J., Theobald A., Jenner P., Perry E.K. In vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol 2000, 52:895-902.
33. Portnoi G., Chng L.A., Karimi-Tabesh L., Koren G., Tan M.P., Einarson A. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 2003, 189:1374-1377.
34. Pratico D., Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 2000, 109:577-585.
35. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorisation assay. Free Rad Biol Med 1999, 26:1231-1237.
36. Rios C., Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 1991, 16:1139-1143.
37. Santamaria D., Espinoza-Gonzalez V., Rios C., Santamaria A. N Omega-nitro-l-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem Res 1999, 24:843-848.
38. Schneider L.J. Treatment of Alzheimer's disease with cholinesterase inhibitors. Clin Geriatr Med 2001, 17:337-339.
39. Stone T.W., Perkins M.N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 1981, 72:411-412.
40. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 2001, 64:185-218.
41. Stone T.W. The neuropharmacology of quinolinic acid and kynurenic acids. Pharmacol Rev 1993, 45:309-379.
42. Tenneti L., Lipton S.A. Involvement of activated caspase-3-like proteases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 2000, 74:134-142.
43. Trease G., Evans W.C. Pharmacognosy 1989, Brailliar Tiridel. Can. Macmillan Publishers. 11th edn.
44. Ursell A. The Complete Guide to Healing Foods 2000, Dorling Kindersley, London, 256pp. ISBN 1-86466-291-3.
45. Zar J.H. Biostatistical Analysis 1984, Prentice-Hall Inc, USA, 620pp. 527.